These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3165250)

  • 1. Immunohistochemical study of osteonectin in various types of osteosarcoma.
    Schulz A; Jundt G; Berghäuser KH; Gehron-Robey P; Termine JD
    Am J Pathol; 1988 Aug; 132(2):233-8. PubMed ID: 3165250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone matrix production in osteosarcoma].
    Schulz A; Loreth B; Battmann A; Knoblauch B; Stahl U; Pollex U; Bohle RM
    Verh Dtsch Ges Pathol; 1998; 82():144-53. PubMed ID: 10095426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies.
    Jundt G; Schulz A; Berghäuser KH; Fisher LW; Gehron-Robey P; Termine JD
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):345-53. PubMed ID: 2496522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein.
    Bosse A; Ueda Y; Wuisman P; Jones DB; Vollmer E; Roessner A
    J Cancer Res Clin Oncol; 1991; 117(1):43-9. PubMed ID: 1997469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistological demonstration of osteonectin in normal bone tissue and in bone tumors.
    Schulz A; Jundt G
    Curr Top Pathol; 1989; 80():31-54. PubMed ID: 2776495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of osteonectin for differential diagnosis of bone tumors. An immunohistochemical approach.
    Bosse A; Vollmer E; Böcker W; Roessner A; Wuisman P; Jones D; Fisher LW
    Pathol Res Pract; 1990 Oct; 186(5):651-7. PubMed ID: 2287591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary giant-cell-rich osteosarcoma of the urinary bladder: usefulness of osteocalcin and osteonectin immunohistochemical staining and literature review.
    Won KY; Lee CH; Kim YW; Park YK
    Pathology; 2011 Feb; 43(2):161-4. PubMed ID: 21233679
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach.
    Park YK; Yang MH; Park HR
    Skeletal Radiol; 1996 Jan; 25(1):13-7. PubMed ID: 8717113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
    Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
    Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
    Fanburg-Smith JC; Bratthauer GL; Miettinen M
    Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a KIT-positive and stem cell factor-producing cell line, KTHOS, derived from human osteosarcoma.
    Hitora T; Yamamoto T; Akisue T; Marui T; Nakatani T; Kawamoto T; Nagira K; Yoshiya S; Kurosaka M
    Pathol Int; 2005 Feb; 55(2):41-7. PubMed ID: 15693848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane.
    Wewer UM; Albrechtsen R; Fisher LW; Young MF; Termine JD
    Am J Pathol; 1988 Aug; 132(2):345-55. PubMed ID: 3400777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors.
    Serra M; Morini MC; Scotlandi K; Fisher LW; Zini N; Colombo MP; Campanacci M; Maraldi NM; Olivari S; Baldini N
    Hum Pathol; 1992 Dec; 23(12):1326-31. PubMed ID: 1468768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo implantation of human osteosarcoma cells in nude mice induces bones with human-derived osteoblasts and mouse-derived osteocytes.
    Hara A; Ikeda T; Nomura S; Yagita H; Okumura K; Yamauchi Y
    Lab Invest; 1996 Nov; 75(5):707-17. PubMed ID: 8941216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteosarcoma metastatic to adrenal gland diagnosed by fine-needle aspiration.
    Siddiqui NH; Jani J
    Diagn Cytopathol; 2005 Sep; 33(3):201-4. PubMed ID: 16078243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor binding of osteoblast-specific factor 1 (OSF-1/HB-GAM) to human osteosarcoma cells promotes cell attachment.
    Gieffers C; Engelhardt W; Brenzel G; Matsuishi T; Frey J
    Eur J Cell Biol; 1993 Dec; 62(2):352-61. PubMed ID: 7925491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
    Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
    Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
    Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
    Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
    Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay for osteonectin. Concentrations in bone, nonmineralized tissues, and blood.
    Malaval L; Fournier B; Delmas PD
    J Bone Miner Res; 1987 Oct; 2(5):457-65. PubMed ID: 3455629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.